Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Neurology|August 9, 2013
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patientsNicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Treatment choices and neuropsychological symptoms of a large cohort of early MSOlga von Bismarck, Theresa Dankowski, Björn Ambrosius, et al.
European Journal of Neurology|August 19, 2021
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)Nina N Kleineberg, Samuel Knauss, Eileen Gülke, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseasesMuriel Schraad, Mathias Mäurer, Anke Salmen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Journal of Neuroimmunology|November 18, 2018
Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort studyPoul Erik H Jensen, Clemens Warnke, Kathleen Ingenhoven, et al.
Neurology|October 1, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European CohortMarius Ringelstein, Susanna Asseyer, Gero Lindenblatt, et al.
Pageof 13